Skip to content

Predictive value of noninvasive serological liver fibrosis diagnostic model on liver failure and overall survival rate after liver cancer resection

Predictive value of noninvasive serological liver fibrosis diagnostic model on liver failure and overall survival rate after liver cancer resection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035974
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Sponsors

The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with hepatocellular carcinoma confirmed by histopathological examination after operation; 2. The patients were treated for the first time and underwent radical resection; 3. Subjects over 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with obstructive jaundice before operation; 2. Patients who received interventional therapy, chemoradiotherapy or recurrent surgery before operation; 3. Patients with cholangiocarcinoma, liver metastases or other malignant tumors confirmed by histopathology after operation.

Design outcomes

Primary

MeasureTime frame
30-day mortality;90-day mortality;One year survival rate;3-year survival rate;5-year survival rate;Overall survival rate;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
Postoperative liver failure;

Countries

China

Contacts

Public ContactZhao Jinming

The First Affiliated Hospital of Xinjiang Medical University

zhaojinmingmed@126.com+86 13565914750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026